Kato Hiroki, Kawai Kazushige, Nakano Daisuke, Dejima Akira, Ise Ichiro, Natsume Soichiro, Takao Misato, Shibata Satomi, Iizuka Toshiro, Akimoto Tetsuo, Tsukada Yuichiro, Ito Masaaki
Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.
J Anus Rectum Colon. 2024 Jul 30;8(3):195-203. doi: 10.23922/jarc.2023-057. eCollection 2024.
To clarify whether self-expandable metallic stent (SEMS) placement for obstructive colorectal cancer (CRC) increases perineural invasion (PNI), thereby worsening the prognosis.
In total, 1022 patients with pathological T3 or T4 colon or rectosigmoid cancer who underwent resection were retrospectively reviewed. The study patients were divided into a no obstruction group (n=693), obstruction without stent group (n=251), and obstruction with stent group (n=78), and factors demonstrating an independent association with PNI, the difference in PNI incidence and severity between groups, and the association between PNI and the duration from SEMS placement to surgery were investigated. Survival analysis was performed for each group.
On multivariate analysis, SEMS placement (hazard ratio [HR]: 2.08) was independently associated with PNI whereas SEMS placement was not. PNI occurred in 39%, 45%, and 68% of the no obstruction, obstruction without stent, and obstruction with stent group, respectively. In the obstruction with stent group, the proportion of PNI was not associated with the duration from SEMS placement to surgery. Extramural PNI, an advanced form of PNI, demonstrated no increase with increasing interval. The five-year OS was 86.3%, 76.7%, and 73.1% in no obstruction, obstruction without stent, and obstruction with stent group, respectively. On multivariate analysis, obstruction was an independent risk factor of decreased OS (HR: 1.57) whereas SEMS placement was not.
The prognosis was comparable between patients with SEMS placement and those with an obstruction who did not undergo SEMS placement, thus demonstrating that SEMS is a viable, therapeutic option for BTS.
明确自膨式金属支架(SEMS)置入治疗梗阻性结直肠癌(CRC)是否会增加神经周围侵犯(PNI),从而使预后恶化。
对1022例行手术切除的病理T3或T4期结肠癌或直肠乙状结肠癌患者进行回顾性研究。研究患者分为无梗阻组(n = 693)、无支架梗阻组(n = 251)和有支架梗阻组(n = 78),研究与PNI独立相关的因素、组间PNI发生率和严重程度的差异以及PNI与SEMS置入至手术时间的关系。对每组进行生存分析。
多因素分析显示,SEMS置入(风险比[HR]:2.08)与PNI独立相关,而SEMS置入并非如此。无梗阻组、无支架梗阻组和有支架梗阻组的PNI发生率分别为39%、45%和68%。在有支架梗阻组中,PNI的比例与SEMS置入至手术的时间无关。壁外PNI(PNI的一种晚期形式)并未随时间间隔增加而增加。无梗阻组、无支架梗阻组和有支架梗阻组的5年总生存率分别为86.3%、76.7%和73.1%。多因素分析显示,梗阻是总生存率降低的独立危险因素(HR:1.57),而SEMS置入并非如此。
SEMS置入患者与未行SEMS置入的梗阻患者的预后相当,因此表明SEMS是治疗良性肿瘤性狭窄(BTS)的一种可行的治疗选择。